Telehealth Ketamine in North Carolina: Access, Laws, and What to Know

Telehealth ketamine in North Carolina is legal when a licensed prescriber follows the federal Ryan Haight Online Pharmacy Consumer Protection Act standard together with North Carolina Medical Board telehealth rules. Ketamine is a Schedule III controlled substance, so a prescriber must complete a real-time audio-visual evaluation and establish a valid provider-patient relationship before sending a prescription to a pharmacy. As of 2026, North Carolina has not added state-specific restrictions on top of the federal baseline, but DEA telehealth flexibilities for controlled substances remain subject to ongoing rulemaking. Patients should confirm current requirements with the North Carolina Medical Board before starting care. This guide covers who can prescribe telehealth ketamine in North Carolina, what NC Medicaid and private insurance typically cover, where to find a compounding pharmacy, and what state residents should know before booking an appointment.

North Carolina's geography ranges from the Appalachian mountains in the west to the Atlantic coastal plain in the east, and access to psychiatric specialists varies sharply between these regions. Telehealth ketamine therapy gives patients in areas with few local prescribers a way to reach treatment for treatment-resistant depression without traveling to Raleigh, Durham, or Charlotte. For a broader look at how telehealth ketamine laws work across the country, see our telehealth legality overview and state-by-state regulations guide.

North Carolina regulates telehealth ketamine prescribing through a mix of state statute and North Carolina Medical Board policy. The North Carolina Medical Board allows physicians to establish a valid provider-patient relationship through telehealth, provided the visit meets the same standard of care as an in-person encounter. The North Carolina Board of Pharmacy regulates pharmacy practice and compounding within the state. Ketamine is a Schedule III controlled substance under both federal and North Carolina law, meaning it has an accepted medical use alongside a recognized potential for abuse, and licensed prescribers may prescribe it off-label with appropriate clinical documentation.

Federal telehealth prescribing rules for controlled substances trace back to the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, which generally requires either a prior in-person medical evaluation or reliance on DEA telemedicine flexibilities before a controlled substance can be prescribed remotely. North Carolina is a member of the Interstate Medical Licensure Compact, which streamlines licensing for out-of-state physicians and expands the pool of telehealth ketamine providers available to state residents. North Carolina's Controlled Substances Reporting System, the state's prescription drug monitoring program, requires prescribers to review a patient's controlled substance history before prescribing, which adds a documentation step to ketamine care.

Provider availability for telehealth ketamine in North Carolina is moderate to high. The state's population size and Interstate Medical Licensure Compact membership attract national telehealth platforms, and the Research Triangle area (Raleigh, Durham, and Chapel Hill) along with the Charlotte metro area have multiple local and telehealth-based options. Rural western and eastern North Carolina counties have far fewer in-person psychiatric prescribers, which makes telehealth a practical option for patients who would otherwise drive long distances for care. For guidance on evaluating a provider, see our provider selection guide.

North Carolina has an established compounding pharmacy infrastructure. The North Carolina Board of Pharmacy regulates compounding activity in the state and enforces USP compounding standards. Both in-state compounding pharmacies and properly licensed out-of-state pharmacies can prepare and ship ketamine formulations, including sublingual troches, rapid-dissolve tablets, and nasal sprays, to North Carolina patients. To understand how compounded ketamine differs from FDA-approved Spravato, see our comparison of generic ketamine and Spravato.

Insurance coverage for off-label ketamine therapy in North Carolina is limited, which matches national coverage patterns described in our insurance versus cash-pay guide. Most private insurers in the state do not cover ketamine for psychiatric indications, and NC Medicaid, administered by the NC Department of Health and Human Services Division of Health Benefits, does not typically cover off-label ketamine for mental health conditions. Medicaid may cover Spravato (esketamine) with prior authorization when a patient meets treatment-resistant depression criteria.

North Carolina expanded Medicaid eligibility in 2023, which increased healthcare access for many residents, though the expansion does not itself add ketamine coverage. Typical out-of-pocket costs for telehealth ketamine in North Carolina range from $200 to $500 for an initial evaluation and $100 to $300 per month for ongoing treatment, though exact pricing varies by provider and formulation. For a breakdown of pricing models, see our cost and payment guide and subscription models overview.